Recro Pharma (REPH:NAS) Fundamental Valuation Report
Recro Pharma (REPH:NAS) Fundamental Valuation Report
Fundamental Valuation Report Recro Pharma(REPH:NAS) Healthcare:Drug Manufacturers – Specialty & Generic This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.99 (USD) 04/01/2021 Weighted Valuation$3.62 (USD) Overall RatingUndervalued by 21.0% Valuation Models Discounted Cash Flow: $6.57…
View On WordPress










